EurekAlert!

New meta-analysis demonstrates that access to the GeneSight test can significantly improve ...

SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...
Open Heart

Wearable cardioverter defibrillator for transient arrhythmic risk and sudden cardiac death ...

Background Sudden cardiac death (SCD) is a common cause of cardiovascular mortality, often triggered by ventricular ...
Business Wire

Independent Systematic Review and Meta-Analysis Attests to the Significant Risk ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a new ...
Business Insider

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve ...

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta ...
ascopubs.org

Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of ...

We systematically searched PubMed, Embase, and Scopus for phase III randomized controlled trials (RCTs) leading to BC drug approval between 2013 and 2023 that had available hazard ratios (HRs) for ...
News Medical

GeneSight test improves outcomes in major depressive disorder, meta-analysis shows

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies that included 3,532 ...